# Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/gemtuzumab-ozogamicin-go-inclusion-to-induction-chemotherapy-eliminates-leukemic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Cathy C. Zhang,Zhengming Yan,Bernadette Pascual,Amy Jackson-Fisher,Donghui Huang,Qing Zong,Mark Elliott,Conglin Fan,Nanni Huser,Joseph Lee,Matthew Sung,Puja Sapra |
| Citations | 25 |
| DOI | 10.1016/j.neo.2017.10.008 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.sciencedirect.com/science/article/pii/S1476558617304190/pdf |
| OpenAlex ID | https://openalex.org/W2768259422 |
| PMID | 29172076 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Mark Elliott](https://scholariq.org/researchers/mark-elliott/)

## Paper primary topic

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Paper topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.